• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc REGN

Last Price$391.34Day Change (%)0.47%
Open Price$391.40Day Change ($)1.82
Day Range387.43–392.6052-Week Range329.09–605.93

As of Fri 7/22/2016 5:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020

    Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020

  2. Global Hypercholesterolemia Pipeline Report 2016 - Therapeutics Review of 36 Companies & Drug Profile Activity - Research and Markets

    Global Hypercholesterolemia Pipeline Report 2016 - Therapeutics Review of 36 Companies & Drug Profile Activity - Research and Markets

  3. Our 5 Nominees for Domestic-Stock Fund Manager of the Year

    Standing out in a good year for stocks.

  4. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  5. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  6. Aberdeen to Buy Artio Global Investors

    As part of Aberdeen's acquisition of Artio, some international fund managers to depart. Also, a management change on a T. Rowe Price health-care fund, Columbia hires Putnam's former asset-allocation head, and ClearBridge and Legg Mason Capital Management funds to merge.

  7. Morningstar Indexes: Weekly Market Report

    Week ending Nov. 10: Investors remain optimistic about direction of economy.

  8. Actavis' Wide-Moat Transformation Offers Shareholder Rewards

    Product durability, diversification, and cost synergies support strong earnings growth for this undervalued wide-moat firm.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.